ACCESSION: MSBNK-SMB_Measured-HSA001P0140014
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.14, Processed 2025.02.21, Annotated 2025.04.02, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 11
COMMENT: RAW_SPEC {'7_posi_817': {'bp': 874404.0, 'sum': 2172187.0}, '2_posi_796': {'bp': 771723.0, 'sum': 2048090.0}, '8_posi_815': {'bp': 824153.0, 'sum': 2141267.0}, '12_posi_837': {'bp': 858075.0, 'sum': 2162889.0}, '10_posi_816': {'bp': 699468.0, 'sum': 1912463.0}, 'BLK02_818': {'bp': 814245.0, 'sum': 2216504.0}, '1_posi_814': {'bp': 821525.0, 'sum': 2255143.0}, '15_posi_816': {'bp': 768366.0, 'sum': 1999888.0}, 'ProcedureBlank_794': {'bp': 813542.0, 'sum': 2170748.0}, '5_posi_817': {'bp': 760043.0, 'sum': 1928308.0}, '13_posi_817': {'bp': 776816.0, 'sum': 2032385.0}}
COMMENT: RETENTION_TIME_STDEV 0.023
COMMENT: PRECURSOR_M/Z_RAW 140.081546
COMMENT: PRECURSOR_M/Z_STDEV 0.000034
COMMENT: PRECURSOR_IN_MS1 ND
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.360; C6H9N3O; [M+H]+; delta(ppm) 0.359519
COMMENT: PROPOSED_MF MS-FINDER 3.397; C6H9N3O; [M+H]+; delta(ppm) 0.354341
COMMENT: PROPOSED_MF SIRIUS6_Sirius 7.220; C6H9N3O; [M+H]+; delta(ppm) 0.354341
COMMENT: PROPOSED_MF SIRIUS6_Sirius 0.079; C3H10FN3O2; [M+H]+; delta(ppm) -7.802640
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.763; C8H11O2; [M+H]+; delta(ppm) -9.230421
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.790; C4H7N6; [M+H]+; delta(ppm) 9.939288
COMMENT: PROPOSED_MF SIRIUS6_Sirius -4.672; CH11N6S; [M+H]+; delta(ppm) -14.126018
COMMENT: PROPOSED_MF SIRIUS6_Sirius -4.739; C2H12N4OP; [M+H]+; delta(ppm) -1.852244
COMMENT: PROPOSED_MF SIRIUS6_Sirius -7.703; H10N7P; [M+H]+; delta(ppm) 7.732660
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C6H9N3O; [M+H]+; delta(ppm) 0.354341
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.556; UPMMUUFLHUEUKP-UHFFFAOYSA-N; [M+H]+; C1CNCC2=C1C(=O)NN2
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.515; BOJJYWPYGHMXDH-UHFFFAOYSA-N; [M+H]+; CCN1C(N)=CC=NC1=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.487; VUTBELPREDJDDH-UHFFFAOYSA-N; [M+H]+; CC1=NC=C(CO)C(N)=N1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.467; ZULCYKWRRGZJJR-UHFFFAOYSA-N; [M+H]+; CCOC1=NC=CN=C1N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.458; XMPLPXUYWIJXFL-UHFFFAOYSA-N; [M+H]+; C1COCCN1N=CC#N
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.770; VYOIELONWKIZJS-UHFFFAOYNA-N; [M+H]+; Histidinal
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.636; VUTBELPREDJDDH-UHFFFAOYSA-N; [M+H]+; 4-Amino-5-hydroxymethyl-2-methylpyrimidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.116; BOJJYWPYGHMXDH-UHFFFAOYSA-N; [M+H]+; 3-ethylcytosine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.116; UPMMUUFLHUEUKP-UHFFFAOYSA-N; [M+H]+; 1,2,4,5,6,7-hexahydropyrazolo[3,4-c]pyridin-3-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.116; XMPLPXUYWIJXFL-UHFFFAOYSA-N; [M+H]+; 2-morpholin-4-yliminoacetonitrile
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.116; ZULCYKWRRGZJJR-UHFFFAOYSA-N; [M+H]+; 3-ethoxypyrazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; VYOIELONWKIZJS-UHFFFAOYNA-N; [M+H]+; Histidinal
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.899; BOJJYWPYGHMXDH-UHFFFAOYSA-N; [M+H]+; 3-ethylcytosine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.862; XMPLPXUYWIJXFL-UHFFFAOYSA-N; [M+H]+; 2-morpholin-4-yliminoacetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.356; UPMMUUFLHUEUKP-UHFFFAOYSA-N; [M+H]+; 1,2,4,5,6,7-hexahydropyrazolo[3,4-c]pyridin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.329; VUTBELPREDJDDH-UHFFFAOYSA-N; [M+H]+; 4-Amino-5-hydroxymethyl-2-methylpyrimidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.302; ZULCYKWRRGZJJR-UHFFFAOYSA-N; [M+H]+; 3-ethoxypyrazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 4.000; VYOIELONWKIZJS-UHFFFAOYSA-N; [M+H]+; 2-amino-3-(1H-imidazol-5-yl)propanal
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.979; VUTBELPREDJDDH-UHFFFAOYSA-N; [M+H]+; (4-amino-2-methylpyrimidin-5-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.585; WEPOCTWSRWLQLL-UHFFFAOYSA-N; [M+H]+; 6-methoxypyridine-2,3-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.255; XHOFWFVNVHZGMB-UHFFFAOYSA-N; [M+H]+; N,N-dimethyl-1H-pyrazole-4-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.183; DQLTWJREEUSJEQ-UHFFFAOYSA-N; [M+H]+; N,N-dimethylimidazole-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.175; IRMKADIQKLRPIG-UHFFFAOYSA-N; [M+H]+; 3-amino-1-ethylpyrazin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.166; XMPLPXUYWIJXFL-KRXBUXKQSA-N; [M+H]+; (2E)-2-morpholin-4-yliminoacetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.133; CCJTVMMVCCNBJG-UHFFFAOYSA-N; [M+H]+; 4-methyl-3-oxopiperazine-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.078; XOQLCZBSKWTPLO-UHFFFAOYSA-N; [M+H]+; 1-(oxetan-3-yl)pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.060; KGMGVOWCSQUUDN-UHFFFAOYSA-N; [M+H]+; 1-(2-aminoethyl)pyrimidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.036; CTQRTRLEFTWDHP-UHFFFAOYSA-N; [M+H]+; 3-(aminomethyl)-1-methylpyrazin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.036; WALXZZKSKMNSRI-UHFFFAOYSA-N; [M+H]+; 3,4-diamino-1-methylpyridin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.032; DVNGOOLQHQHDIA-UHFFFAOYSA-N; [M+H]+; 1,4,6,7-tetrahydropyrano[4,3-c]pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.011; RURXZFAARVJQJG-UHFFFAOYSA-N; [M+H]+; 3,4,6,7-tetrahydropyrano[3,4-d]imidazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.009; APWRLAZEMYLHKZ-UHFFFAOYSA-N; [M+H]+; 2-amino-4,5-dimethyl-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.000; MXQISKATRNDXMJ-UHFFFAOYSA-N; [M+H]+; 2-amino-1-(2-methylpyrazol-3-yl)ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.999; XJOJXINBSJBDHU-UHFFFAOYSA-N; [M+H]+; 5-cyclobutyl-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.999; GTODUQSLRPFYJX-UHFFFAOYSA-N; [M+H]+; 2-amino-1-(1-methylpyrazol-4-yl)ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.997; XBWPMCBABWSUNG-UHFFFAOYSA-N; [M+H]+; 6,7-dihydro-4H-pyrazolo[5,1-c][1,4]oxazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.992; NXZCEONGJPCYGX-UHFFFAOYSA-N; [M+H]+; 6,7-dihydro-4H-pyrazolo[5,1-c][1,4]oxazin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.987; LHTJITWSNBQNJM-UHFFFAOYSA-N; [M+H]+; 1-(1,2,4-triazol-1-yl)butan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.984; JAZSELZAGUGQPR-UHFFFAOYSA-N; [M+H]+; 2-propyl-1,2,4-triazole-3-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.983; YEOXPHBIXHBTOZ-UHFFFAOYSA-N; [M+H]+; 4-(1,2,4-triazol-1-yl)butan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.983; ANLVMPLXUXEQBJ-UHFFFAOYSA-N; [M+H]+; 5-pyrrolidin-2-yl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.980; XWFOGRSJKBTDTK-UHFFFAOYSA-N; [M+H]+; [1-(1,2,4-oxadiazol-5-yl)cyclopropyl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.971; DTAFNVJRXJKUTM-UHFFFAOYSA-N; [M+H]+; 3-pyrrolidin-3-yl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.968; BOXYGLCLAXTSAI-UHFFFAOYSA-N; [M+H]+; 6,8-dihydro-5H-imidazo[2,1-c][1,4]oxazin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.963; VFWAWGNLESCBDG-UHFFFAOYSA-N; [M+H]+; 4-amino-1-methylpyrrole-2-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.961; WYIBEJSJURTLIG-UHFFFAOYSA-N; [M+H]+; 1-(2-methyl-1,2,4-triazol-3-yl)propan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.952; RKORKXLEGJOTTK-UHFFFAOYSA-N; [M+H]+; 1-(oxetan-3-yl)pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.951; WCTKTNLZDXKQNS-UHFFFAOYSA-N; [M+H]+; 2-(2-aminoethyl)pyridazin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.946; SLZGMEJPWRRFIO-UHFFFAOYSA-N; [M+H]+; 7-amino-2,3-dihydro-1H-pyrazolo[1,2-a]pyrazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.929; KXOXEIRPXQUVET-UHFFFAOYSA-N; [M+H]+; 2,3,6,7-tetrahydro-1H-imidazo[1,2-a]pyrimidin-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.906; VFAFDDVJGKOBTH-UHFFFAOYSA-N; [M+H]+; N-(1H-pyrazol-4-ylmethyl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.905; SXKAQLCLHGQXHB-UHFFFAOYSA-N; [M+H]+; N-(1H-imidazol-2-ylmethyl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.893; FMHSWVAWPDYUJH-UHFFFAOYSA-N; [M+H]+; 1-(3-methyl-1,2,4-oxadiazol-5-yl)cyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.890; VFIHAWGAYBQVAE-UHFFFAOYSA-N; [M+H]+; 6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.889; CRAAVDCTMCOCNX-UHFFFAOYSA-N; [M+H]+; 6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.888; YJUTYBZBQLBFJO-UHFFFAOYSA-N; [M+H]+; 5-(azetidin-3-yl)-3-methyl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.847; SNWZXTZIZWBIDQ-UHFFFAOYSA-N; [M+H]+; 4-methoxy-6-methylpyrimidin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.835; WLNIMHJTXBDWNO-UHFFFAOYSA-N; [M+H]+; N-ethylimidazole-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.835; SUYLOMATYCPVFT-UHFFFAOYSA-N; [M+H]+; 2,4,6-triaminophenol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.790; WPVIOWUUAXJYOS-UHFFFAOYSA-N; [M+H]+; 2-(3-oxopiperazin-1-yl)acetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.770; DNVNVWZQZDEHMD-UHFFFAOYSA-N; [M+H]+; (5-cyclopropyl-1,3,4-oxadiazol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.768; XNZBBRSOQRITIK-UHFFFAOYSA-N; [M+H]+; 2-cyano-3-(dimethylamino)prop-2-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.768; CHFIUTHZJHXEKJ-UHFFFAOYSA-N; [M+H]+; 5-methoxy-4-methylpyrimidin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.758; OHHMKIRNPAHPPV-UHFFFAOYSA-N; [M+H]+; (5-cyclopropyl-1,2,4-oxadiazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.752; QIKHXVOOIAHGOB-UHFFFAOYSA-N; [M+H]+; (3-cyclopropyl-1,2,4-oxadiazol-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.744; WLBJSXRTEVTGGG-UHFFFAOYSA-N; [M+H]+; 1,6-diamino-4-methylpyridin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.743; ATFSESSLTKRXKN-UHFFFAOYSA-N; [M+H]+; 3-pyrrolidin-2-yl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.742; JELQPVSROGURLI-UHFFFAOYSA-N; [M+H]+; 1-(1,2,4-oxadiazol-3-yl)cyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.738; ZAVANOZVUHPQEM-UHFFFAOYSA-N; [M+H]+; 3-amino-5,6,7,7a-tetrahydropyrrolo[1,2-c]imidazol-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.733; KFEIXQJTNLBBLR-UHFFFAOYSA-N; [M+H]+; 1-propan-2-yltriazole-4-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.732; RVYPXKJNPYRZLH-UHFFFAOYSA-N; [M+H]+; 1-propyltriazole-4-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.721; FRWMDMMESWEKFU-UHFFFAOYSA-N; [M+H]+; 4-propan-2-yl-1,2,4-triazole-3-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.711; ZZXMSNXYVWPTBO-UHFFFAOYSA-N; [M+H]+; 1-(1-ethyltriazol-4-yl)ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.708; GMEONBANQFZLSE-UHFFFAOYSA-N; [M+H]+; 6-ethoxypyridazin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.695; IRMMPGYRIXATFO-UHFFFAOYSA-N; [M+H]+; 1-(5-amino-1-methylpyrazol-4-yl)ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.685; OJJIBQJQYBAKQH-UHFFFAOYSA-N; [M+H]+; (6-methoxypyridazin-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.673; AUNQXUFJXZBTIV-UHFFFAOYSA-N; [M+H]+; 2-(methoxymethyl)pyrimidin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.664; BATVWQIPSVQPEI-UHFFFAOYSA-N; [M+H]+; 2-amino-4,6-dimethylpyrimidin-5-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.662; VNJXPEWQUVGHKM-UHFFFAOYSA-N; [M+H]+; 5,6,7,8-tetrahydro-2H-[1,2,4]triazolo[4,3-a]pyridin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.661; WDGIZDYDCQXBDL-UHFFFAOYSA-N; [M+H]+; (2-methoxypyrimidin-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.657; GPPSMTQRFHCIEZ-YFKPBYRVSA-N; [M+H]+; (2R)-2-amino-2-pyrazin-2-ylethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.655; PSTACWJBJZYESW-UHFFFAOYSA-N; [M+H]+; 5-(aminomethyl)-2-methyl-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.649; AIEWKBISOOGENG-UHFFFAOYSA-N; [M+H]+; N-(5-methyl-1H-imidazol-2-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.648; GAQOJPOWNPLPHR-UHFFFAOYSA-N; [M+H]+; (6-methoxypyrimidin-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.644; FTWYAOBHRPLHQG-UHFFFAOYSA-N; [M+H]+; 4-amino-2,5-dimethyl-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.637; MVCKCFNBLYFTSC-UHFFFAOYSA-N; [M+H]+; 5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyridin-8-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.632; LGFHMAHXLFPNMS-UHFFFAOYSA-N; [M+H]+; 3-methoxy-5,6-dimethyl-1,2,4-triazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.629; AMUAVKXIRPMUBN-UHFFFAOYSA-N; [M+H]+; 1,2,4,5,6,7-hexahydropyrazolo[4,3-c]pyridin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.626; TWOIVVCRUURYCJ-UHFFFAOYSA-N; [M+H]+; 6-(2-aminoethyl)-1H-pyrimidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.626; GMXDHHPKBRZRSJ-UHFFFAOYSA-N; [M+H]+; 4-amino-5-ethyl-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.625; JHVHBOSLWJNDIQ-UHFFFAOYSA-N; [M+H]+; 5,6-dihydro-4H-pyrrolo[1,2-c]triazol-3-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.624; GYMJWRLDQXXOIX-UHFFFAOYSA-N; [M+H]+; 1,3,4,5,6,7-hexahydroimidazo[4,5-c]pyridin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.624; CHMWJKNFUJFZFS-UHFFFAOYSA-N; [M+H]+; 4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.623; UPMMUUFLHUEUKP-UHFFFAOYSA-N; [M+H]+; 1,2,4,5,6,7-hexahydropyrazolo[3,4-c]pyridin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.619; SOGRSFRXDSKWFT-UHFFFAOYSA-N; [M+H]+; 4-(dimethylamino)pyrimidin-5-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.612; NQUHWZJWGWWYGB-UHFFFAOYSA-N; [M+H]+; 2-(aminomethyl)-4-methyl-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.610; KVUIXDYVMBZNNR-UHFFFAOYSA-N; [M+H]+; 1-(1,3-oxazol-2-yl)azetidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.608; AEIZOZZULKSQDC-UHFFFAOYSA-N; [M+H]+; 2-(2-aminoethyl)-1H-pyrimidin-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.599; FSOMDUWOVKREMM-UHFFFAOYSA-N; [M+H]+; 2-ethyl-5-methyltriazole-4-carbaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.571; NIQNPTQRAGJGPS-UHFFFAOYSA-N; [M+H]+; 3-methoxy-5-methylpyrazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.563; SRQWKLIXHJRVSG-UHFFFAOYSA-N; [M+H]+; (6-methoxypyridin-3-yl)hydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.562; YAIFNSSQKVRCSO-UHFFFAOYSA-N; [M+H]+; 2-methoxypyridine-3,4-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.560; ZEEJRACEEDQANN-UHFFFAOYSA-N; [M+H]+; 6-(methoxymethyl)pyrimidin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.556; TZSLKMXBFQUHIZ-UHFFFAOYSA-N; [M+H]+; 6-ethoxypyrazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.554; NFENSUDOADHXHX-UHFFFAOYSA-N; [M+H]+; 5-ethoxypyrazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.554; OUOPDDNPXZHMDY-UHFFFAOYSA-N; [M+H]+; 2-pyrimidin-2-yloxyethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.552; MRMAANKLHANZFQ-UHFFFAOYSA-N; [M+H]+; 4-methoxy-6-methylpyridazin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.552; KJXYUBAPURRRBQ-UHFFFAOYSA-N; [M+H]+; 5-(methoxymethyl)pyrazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.550; NDBSWKMPQRFLQA-UHFFFAOYSA-N; [M+H]+; (4-methoxypyrimidin-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.549; BVMYMEWFWASOAB-UHFFFAOYSA-N; [M+H]+; (5-methoxypyridin-2-yl)hydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.547; CPJKUVZCSBKHKL-UHFFFAOYSA-N; [M+H]+; (2-methoxypyridin-3-yl)hydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.546; BYKHMSRXEDLDRS-UHFFFAOYSA-N; [M+H]+; (6-methoxypyridin-2-yl)hydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.544; MIHLPTOONCZPHD-UHFFFAOYSA-N; [M+H]+; (6-methoxypyrazin-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.541; CTDGZTYCKKQAHV-UHFFFAOYSA-N; [M+H]+; 6-methoxy-N-methylpyrazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.541; HDQLILNOJXZFHV-UHFFFAOYSA-N; [M+H]+; (2-methoxypyridin-4-yl)hydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.541; FUWCQMCZXDHMKH-UHFFFAOYSA-N; [M+H]+; (5-methoxypyrazin-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -102.540; DQLTWJREEUSJEQ; [M+H]+; Dqltwjreeusjeq-uhfffaoysa-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -119.720; QIQICVKRWUAGNC; [M+H]+; N,N-dimethyl-1H-imidazole-2-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -135.132; AKRDSDDYNMVKCX; [M+H]+; 3,5-Dimethyl-1H-pyrazole-1-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -141.567; SXKAQLCLHGQXHB; [M+H]+; N-[(1H-imidazol-2-yl)methyl]acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -143.106; IRMKADIQKLRPIG; [M+H]+; 3-Amino-1-ethyl-1,2-dihydropyrazin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -146.036; BOJJYWPYGHMXDH; [M+H]+; 3-Ethylcytosine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -156.364; CTDGZTYCKKQAHV; [M+H]+; 6-Methoxy-N-methylpyrazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -156.574; XHOFWFVNVHZGMB; [M+H]+; N,N-dimethyl-1H-pyrazole-4-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -168.501; NDBSWKMPQRFLQA; [M+H]+; (4-Methoxypyrimidin-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -168.867; NIQNPTQRAGJGPS; [M+H]+; 3-Methoxy-5-methylpyrazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.363; DQLTWJREEUSJEQ; [M+H]+; Dqltwjreeusjeq-uhfffaoysa-
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C6H10N3O1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1);
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 1.637
MS$FOCUSED_ION: PRECURSOR_M/Z 140.081888
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0006-2900000000-0aaa94b7a3f71b3b0562
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  56.0494716 6.1772 56.050103 1.7128 2.07 -0.1167 9 f{C3H6N1}/-0.07ppm,p-C3H4N2O1
  69.0447371 200.5522 69.045363 0.2897 15.71 0.0727 11 f{C3H5N2}/0.18ppm,p-C3H5N1O1
  70.0651478 35.3657 70.065767 1.0847 3.06 0.7909 11 f{C4H8N1}/0.32ppm,p-C2H2N2O1
  71.0604032 37.1286 71.061016 0.6192 3.76 0.4636 11 f{C3H7N2}/0.40ppm,p-C3H3N1O1
  72.0443971 149.7581 72.045004 0.3748 6.42 0.7364 11 f{C3H6N1O1}/0.10ppm,p-C3H4N2
  81.0446536 9.7895 81.045180 1.1105 1.82 0.4273 11 f{C4H5N2}/-0.88ppm,p-C2H5N1O1
  83.0602663 10.0649 83.060770 1.1197 2.66 0.2273 11 f{C4H7N2}/-1.30ppm,p-C2H3N1O1
  84.0680547 7.1964 84.068546 1.8794 1.64 0.1182 11 f{C4H8N2}/-1.72ppm,p-C2H2N1O1
  85.0759572 11.7298 85.076436 0.8228 2.53 0.1909 11 f{C4H9N2}/-0.79ppm,p-C2H1N1O1
  95.0602901 8.5115 95.060650 1.8935 1.96 0.1636 11 f{C5H7N2}/-0.89ppm,p-C1H3N1O1
  96.0681520 12.7183 96.068505 0.9785 2.85 -0.1182 11 f{C5H8N2}/-0.50ppm,p-C1H2N1O1
  97.0760514 54.4324 97.076396 0.4223 6.97 0.0727 11 f{C5H9N2}/0.28ppm,p-C1H1N1O1
  98.9841745 7.9646 98.984504 1.9700 1.51 0.5091 11 ?
  99.0552573 5.5893 99.055587 2.3118 1.83 -0.4833 9 f{C4H7N2O1}/-0.32ppm,p-C2H3N1
  111.0917126 21.2045 111.091928 1.0172 3.53 0.3545 11 ?
  112.0870109 27.1561 112.087215 1.5078 3.35 0.1364 11 f{C5H10N3}/0.78ppm,p-C1O1
  113.0709209 11.9702 113.071114 1.2116 2.49 -0.5636 11 f{C5H9N2O1}/-0.16ppm,p-C1H1N1
  119.6049271 7.4897 119.605042 1.6053 2.63 0.2485 10 ?
  122.0713219 18.0507 122.071404 1.8514 3.51 -0.0636 11 f{C6H8N3}/0.40ppm,p-H2O1
  123.0553771 40.2468 123.055446 1.1783 7.45 0.2909 11 f{C6H7N2O1}/0.71ppm,p-H3N1
  123.0915662 5.6190 123.091635 2.6972 1.62 0.3571 8 ?
  125.0948216 25.4243 125.094863 1.3190 3.13 0.7273 11 ?
  138.1026058 5.8743 138.102511 2.0564 1.24 0.2619 8 ?
  140.0818548 999.0000 140.081759 0.3712 0.00 1.0000 11 f{C6H10N3O1}/0.12ppm,p
  140.1181649 847.0121 140.118069 0.3283 64.91 0.5727 11 ?
PK$NUM_PEAK: 25
PK$PEAK: m/z int. rel.int.
  56.049472 6.18 6
  69.044737 200.55 200
  70.065148 35.37 35
  71.060403 37.13 37
  72.044397 149.76 149
  81.044654 9.79 9
  83.060266 10.06 10
  84.068055 7.20 7
  85.075957 11.73 11
  95.060290 8.51 8
  96.068152 12.72 12
  97.076051 54.43 54
  98.984174 7.96 7
  99.055257 5.59 5
  111.091713 21.20 21
  112.087011 27.16 27
  113.070921 11.97 11
  119.604927 7.49 7
  122.071322 18.05 18
  123.055377 40.25 40
  123.091566 5.62 5
  125.094822 25.42 25
  138.102606 5.87 5
  140.081855 999.00 999
  140.118165 847.01 847
//
